Research output per year
Research output per year
Search results
-
2020
HOVON110/ReBeL Study: Results of the phase i part of a randomized phase I/II study of lenalidomide, rituximab with or without bendamustine in patients with relapsed/refractory follicular lymphoma
Stevens, W. B. C., Bakunina, K., Cuijpers, M., Chamuleau, M., Beeker, A., Fijnheer, R., Hebart, H., Visser, H. P. J., Doorduijn, J. K., Linton, K., Dreyling, M., De Jong, D. & Kersten, M. J., Feb 2020, In: HemaSphere. 4, 1, p. e325 e325.Research output: Contribution to journal › Letter › peer-review
Open Access